Welcome to the Official website of National Federation of Postal employees । नेशनल फेडरेशन ऑफ़ पोस्टल एम्प्लाइज की आधिकारिक वेबसाइट पर आपका स्वागत है।

Thursday, December 31, 2020

 





 

TRAVELLING ALLOWANCE RULES- PRODUCTION OF RECEIPTS/VOUCHERS FOR REIMBURSEMENT OF TRAVELLING CHARGES FOR TRAVEL WITHIN THE CITY ADMISSIBLE UNDER DAILY ALLOWANCE ON TOUR CLICK THE BELOW LINK TO VIEW

http://utilities.cept.gov.in/dop/pdfbind.ashx?id=5151

*********************

REVISION OF INTEREST RATES FOR THE SMALL SAVINGS SCHEMES FOR THE 4TH QUARTER OF THE YEAR 2020-21


*********************

REIMBURSEMENT OF COST OF OPD MEDICINES : SPECIAL SANCTION IN VIEW OF COVID19 TILL 28TH FEBRUARY 2021 (CLICK THE BELOW LINK TO VIEW)

https://cghs.gov.in/showfile.php?lid=5951

*********************

THE DEPARTMENT OF POSTS WINS THE ‘DIGITAL INDIA GOLD AWARD 2020' IN THE CATEGORY OF ‘EXCELLENCE IN DIGITAL GOVERNANCE (CENTRAL MINISTRY AND DEPARTMENT)'

*********************

PRESS NEWS

MINISTRY OF COMMUNICATIONS

POSTAL DEPARTMENT ISSUES NOTICE ON UPDATING CUSTOMS DATA OF ARTICLES CONTAINING GOODS

Posted On: 31 DEC 2020 6:55PM by PIB Delhi

 

Department of Posts, Ministry of Communications, has issued a Public Notice on Updating Customs data of Articles containing goods.

 

The notice states , “ As per rule 47 of Post Office Guide Part 2 and other relevant rules, it is mandatory that all postal articles including ordinary articles containing goods meant for delivery to foreign destinations are affixed with correct and complete relevant custom declaration forms. These forms include details of sender and recipient along with descriptions of the contents of the article.”

Department of Posts reiterated for information of customer/ public that in the absence of correct and complete Custom Declaration forms (CN22/ CN23), such articles will not be processed and will be returned to the sender as per departmental rules.

 

Information of CN forms and other details/ guidelines are available at https://www.indiapost.gov.in/MBE/Pages/Content/MoreInfo.aspx#Custom_forms_and_Regulations  (Release ID: 1685142) Visitor Counter



 

Tuesday, December 29, 2020

FREQUENTLY ASKED QUESTIONS ON COVID-19 VACCINE

FREQUENTLY ASKED QUESTIONS ON COVID-19 VACCINE FOR GENERAL PUBLIC AND HEALTHCARE PROVIDERS/FRONTLINE WORKERS

FREQUENTLY ASKED QUESTIONS ON COVID-19 VACCINE

TARGET GROUP: GENERAL PUBLIC

S.No.

Question

Potential response

1

Is a COVID vaccine scheduled soon anytime?

Yes, vaccine trials are under different stages of finalization. Government of India is geared to launch a vaccine for COVID 19 soon. For more information and updates visit www.mohfw.gov.in

2

Will COVID 19 vaccine be given to everyone simultaneously

Based on the potential availability of vaccines the Government of India has selected the priority groups who will be vaccinated on priority as they are at higher risk.

The first group includes healthcare and frontline workers. The second group to receive COVID 19 vaccine will be persons over 50 years of age and persons under 50 years with comorbid conditions.

3

Is it mandatory to take the vaccine?

Vaccination for COVID-19 is voluntary. However, it is advisable to receive the complete schedule of COVID-19 vaccine for protecting one-self against this disease and also to limit the spread of this disease to the close contacts including family members, friends, relatives and co-workers.

4

Will the vaccine be safe as it is being tested and introduced in a short span of time?

Vaccines will be introduced in the country only after the regulatory bodies clear it based on its safety and efficacy.

 

5.

Can a person presently having COVID-19 (confirmed or suspected) infection be vaccinated?

Person with confirmed or suspected COVID-19 infection may increase the risk of spreading the same to others at vaccination site. For this reason, infected individuals should defer vaccination for 14 days after symptoms resolution.

6.

Is it necessary for a COVID recovered person to take the vaccine?

Yes, it is advisable to receive complete schedule of COVID vaccine irrespective of past history of infection with COVID-19. This will help in developing a strong immune response against the disease.

7

Out of the multiple vaccines available, how is one or more vaccine chosen for administration?

The safety and efficacy data from clinical trials of vaccine candidates are examined by Drug regulator of our country before granting the vaccine chosen for license for the same. Hence, all the COVID-19 vaccines that receive license will have comparable safety and efficacy.However, it must be ensured that the entire schedule of vaccination is completed by only one type of vaccine as different COVID-19 vaccines are not interchangeable.

8

Does India have the capacity to store the COVID vaccine at temperature of +2 to +8 degree Celsius and transport them at
required temperature?

India runs one of the largest Immunization programme in the world, catering to the vaccination needs of more than 26 million newborns and 29 million pregnant women. The programme mechanisms are being strengthened / geared up to effectively cater to the country’s large and diverse population.

 

 

9.

Will the vaccine introduced in India be as effective as the ones introduced in other countries?

Yes. The COVID 19 vaccine introduced in India will be as effective as any vaccine developed by other countries. Various phases of vaccine trials are undertaken to ensure its safety and efficacy.

10.

How will I know if I am eligible for vaccination?

In the initial phase, COVID 19 vaccine will be provided to the priority group- Health Care and Front-line workers.

The 50 plus age group may also begin early based on vaccine availability.

The eligible beneficiaries will be informed through their registered mobile number regarding the Health Facility where the vaccination will be provided and the scheduled time for the same. This will be done to avoid any inconvenience in registration and vaccination of beneficiaries.

11.

Can a person get the COVID-19 vaccine without registration with Health Department?

No, registration of beneficiary is mandatory for vaccination for COVID 19. Only after registration the information on the session site to visit and time will be shared with the beneficiary.

12

What documents are required for registration of eligible beneficiary?

Any of the below mentioned ID with Photo may be produced at the time of registration:

• Driving License
• Health Insurance Smart Card issued under the scheme of Ministry of Labour
• Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) Job Card
• Official identity cards issued to MPs/MLAs/MLCs
• PAN Card
• Passbooks issued by Bank/Post Office
• Passport
• Pension Document
• Service Identity Card issued to employees by Central/ State Govt./ Public Limited Companies
• Voter ID

13

Will a Photo / ID be required at the time of registration?

The Photo ID produced at the time of registration must be produced and verified at the time of vaccination

14

If a person is not able to produce Photo ID at the session site, whether s/he be vaccinated or not?

Photo ID is a must for both registration and verification of beneficiary at session site to ensure that the intended person is vaccinated

15

How will the beneficiary receive information about due date of vaccination?

Following online registration, beneficiary will receive SMS on their registered mobile number on the due date, place and time of vaccination.

 

16.

Will vaccinated beneficiaries receive information on the status of their vaccination after completion?

Yes. On getting due dose of COVID 19 vaccine, the beneficiary will receive SMS on their registered mobile number.After all doses of vaccine are administered, a QR code based certificate will also be sent to the registered mobile number of the beneficiary.

17.

If one is taking medicines for illnesses like Cancer, Diabetes, Hypertension etc, can s/he take the COVID- 19 vaccine?

Yes. Persons with one or more of these comorbid conditions are considered high risk category. They need to get COVID -19 vaccination.

18.

Are there any preventive measures and precautions that one needs to follow at the session site?

We request you to rest at the vaccination centre for atleast half an hour after taking the COVID-19 vaccine. Inform the nearest health authorities ANM ASHA in case you feel any discomfort or uneasiness subsequently.Remember to continue following key COVID Appropriate Behaviours like wearing of mask, maintaining hand sanitization and physical distance (or 6 feet or Do Gaj).

19

What about the possible side-effects from COVID-19 vaccine?

COVID Vaccine will be introduced only when the safety is proven. As is true for other vaccines, the common side effects in some individuals could be mild fever, pain, etc. at the site of injection.

States have been asked to start making arrangements to deal with any Covid-19 vaccine-related side-effects as one of the measures towards safe vaccine delivery among masses.

20.

How many doses of the vaccine would have to be taken by me and at what interval?

Two doses of vaccine, 28 days apart, need to be taken by an individual to complete the vaccination schedule.

21.

When would antibodies develop? After taking first dose, after taking second dose, or much later?

Protective levels of antibodies are generally developed two weeks after receiving the 2nd dose of COVID-19 vaccine.

 

TARGET GROUP: HEALTHCARE PROVIDERS/FRONTLINE WORKERS

Sl No.

Question

Potential response

1.

Why am I being chosen for COVID 19 vaccine?

Government of India has prioritised the most at risk/high risk groups which will get the vaccine first. Healthcare providers have led the battle against COVID 19 from the front. The government wants you to be able to continue your work, without the fear of risk associated with the virus. Therefore, healthcare and frontline workers are among the first group of people to be vaccinated in the country.

 

2.

 

What are the groups to be vaccinated in the first phase?

Based on the potential availability of vaccines the Government of India has selected the priority groups who will be vaccinated on priority as they are at higher risk.

The first group includes healthcare workers because they are at high risk of contracting the infection and protecting them helps to sustain essential health services. The vaccination of frontline workers will help in reducing the societal and economic impact by reducing COVID- 19 mortalities. The next group to receive COVID 19 vaccine will be persons over 50 years of age and persons under 50 years with comorbid conditions because there is high mortality in this category.

The reason for including more than 50 years of age group for vaccination is that it will be able to cover 78% of persons having co-morbidities and thereby reduce mortality on account of COVID-19.

 

More than 50 years of age group is divided into two sub groups. One sub group is 60 years and above, they will be vaccinated first. Second sub- group is between 50 to 60 years age group, they will be vaccinated after the first sub group is covered.

The vaccination may not be sequential. It can go in parallel for all beneficiaries depending on the availability of the vaccine.

3.

Will my family members also be given the vaccine?

Due to the limited vaccine supply in the initial phase, it will first be provided to people who are at higher risk of contracting COVID-19. In subsequent phases the COVID 19 vaccine will be made available to all others in need of the same.

4.

Is this vaccine safe?

Yes. Safety and efficacy of vaccine will be ensured through various phases of vaccine trials and only then a vaccine will be introduced.

5.

Does one need to follow preventive measures such as wearing a mask, hand sanitization, social distancing after receiving the COVID 19 vaccine?

Even after receiving the COVID 19 vaccine, we must continue taking all precautions like use of face cover or masks, hand sanitization and maintain distancing (6 feet or Do Gaj). These behaviours must be followed both at the session site and in general.

6.

Are there any common side- effects of this vaccine?

The COVID 19 vaccine will be safe and effective but may have minor side effects like fever, pain, etc. at the injection site. These effects can happen in any vaccine.

Source: mohf



 PRESS NEWS

YEAR END REVIEW-2020 DEPARTMENT OF POSTS

https://pib.gov.in/PressReleseDetailm.aspx?PRID=1684401

Saturday, December 26, 2020

 SHRI MAHAVEER PRASAD JI BEREAVED

Shri Banwari Lal Sharma Brother of Shri Mahavir Prasad Ji, Office Staff of NFPE (HQ) New Delhi expired yesterday on 25.12.2020 at his native place in Alwar District (Rajasthan). He was suffering from Cancer.

NFPE HQ conveys heartfelt condolences to Shri Mahaveer Prasad Ji and bereaved family.

May his soul Rest in Peace

 

Friday, December 25, 2020

 WARM GREETINGS AND BEST WISHES 

ON THE AUSPICIOUS OCCASION OF CHRISTMAS.

 क्रिसमस के शुभ अवसर पर हार्दिक बधाई और शुभकामनाएं



Tuesday, December 22, 2020

 

TRAVELLING ALLOWANCE RULES – PRODUCTION OF RECEIPTS/VOUCHERS FOR REIMBURSEMENT OF TRAVELLING CHARGES FOR TRAVEL WITHIN THE CITY ADMISSIBLE UNDER DAILY ALLOWANCE ON TOUR

No. 19030/2/2020-E.IV
Government of India
Ministry of Finance
Department of Expenditure

North Block, New Delhi
Dated 22nd December, 2020

OFFICE MEMORANDUM

Subject: Travelling Allowance Rules – production of receipts/vouchers for reimbursement of Travelling charges for travel within the city admissible under Daily Allowance on tour- regarding.

 

The undersigned is directed to refer to Para 2 (E) (i) & (ill) of this Department’s OM No. 19030/1/2017-E.IV dated 13.07.2017 regarding Travelling Allowance Rules — Implementation of 7th CPC vide which reimbursement for Travelling Charges for travel within the city admissible under Daily Allowance on Tour, has been prescribed. As per Para 2E(iii) of this O.M. Level 8 & Below have been allowed reimbursement of Travelling Charges without production of vouchers against self — certification and Level 9 & above have to produce vouchers.

 

2.         Several references have been received in this Department regarding difficulties being faced by the officials in Pay Level 9 to 11 for production of receipts/vouchers while claiming reimbursement of Travelling Charges for travel within the city admissible under Daily Allowance on Tour as per Para 2E(i) of Annexure to this Department’s OM dated 13.07.2017.

 

3.         The matter has been considered in this Department and it has been decided that for reimbursement of Travelling Charges admissible under Daily Allowance on tour as mentioned in Para 2E(i) of OM dated 13.07.2017, condition of production of receipts/vouchers for officials in Pay Level 9 to 11, is done away with subject to furnishing of self-certification in which officials have to indicate the period of travel, vehicle Number etc.

 

4.         In their application to the persons belonging to the Indian Audit & Accounts Department, this order is issued under Article 148(5) of the Constitution and after consultation with the Comptroller & Auditor General of India.

 

9.         This is issued with the approval of Secretary (Expenditure).

Hindi version is attached.

Sd/-
(Nirmala Dev)
Director

To,

All Ministries and Departments of the Govt. of India etc. as per standard distribution list.

Copy to : C&AG and U.P.S.C. etc. as per standard endorsement list.